Moxifloxacin
-
Subject Areas on Research
- Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.
- Clinical Trial in a Dish: Personalized Stem Cell-Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT-Prolonging Drugs.
- Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database.
- Electrocardiographic safety of cangrelor, a new intravenous antiplatelet agent: a randomized, double-blind, placebo- and moxifloxacin-controlled thorough QT study.
- Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.
- Epithelial wound healing after cataract surgery comparing two different topical fluoroquinolones.
- Glucose homeostasis abnormalities associated with use of gatifloxacin.
- Moxifloxacin-induced torsades de pointes.
- Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
- Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.
- Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.
- Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin.
- Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.
- Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.